BioSpace News Archive

Retrophin, Inc. (NASDAQ: RTRX) today reported its fourth quarter and full year 2019 financial results and provided a corporate update.

ALACHUA, Fla., Feb. 24, 2020 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today reported financial results and business highlights for the fourth quarter and full year ended December 31, 2019. Fourth Quarter 2019 Financial Results and Business Highlights Net sales were $28.1 million during the quarter, an increase of 20% compared to fourth quarter 2018 revenue of $23.4 million. G

Avanos Medical, Inc. (NYSE: AVNS) today announced the U.S. Food and Drug Administration (FDA) has cleared for marketing its new, 80-Watt COOLIEF* Radiofrequency (RF) system for neurological lesion procedures

SAN DIEGO , Feb. 24, 2020 /PRNewswire/ -- Avidity Biosciences (Avidity), a privately-held biotechnology company pioneering Antibody Oligonucleotide Conjugates (AOCs™), announced today that Sarah Boyce , Avidity’s President and CEO, will present a company overview at two upcoming investor conferences: 9 th Annual SVB Leerink Global

Feb. 24, 2020 21:01 UTC -- Management to Host Conference Call at 4:30 p.m. ET Today -- MONROVIA, Calif.--( BUSINESS WIRE )-- Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer and autoimmune diseases, today reported financial results for the fourth quarter and full year ended December 31, 2019 and provided a review of recent business and clinical highlights. “Throughout 2019 we

BEDMINSTER, N.J., Feb. 24, 2020 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (“Matinas BioPharma” or the “Company”) -- (NYSE AMER: MTNB), a clinical-stage biopharmaceutical company, today announced that the Company will host a conference call and live audio webcast on Monday, March 9, 2020 at 8:00 a.m. ET to discuss operational and financial results for the fourth quarter and full year ended December 31, 2019. To participate in the call, please dial (877) 407-5976 (domestic) or (412)

Feb. 24, 2020 21:05 UTC IRVINE, Calif.--( BUSINESS WIRE )-- Masimo (NASDAQ: MASI) today announced that its management is scheduled to present at the Raymond James 41st Annual Institutional Investors Conference at the JW Marriott Grande Lakes Hotel in Orlando on Monday, March 2, 2020 at 1:05 p.m. Eastern Time. A live audiocast of the presentation will be available on the Masimo website at www.masimo.com . A replay of the audiocast will be available following the live presentatio

Tandem Diabetes Care, Inc., a leading insulin delivery and diabetes technology company, reported its financial results for the quarter and year ended December 31, 2019 and financial guidance for the year ending December 31, 2020.

Feb. 24, 2020 21:15 UTC Dexcom to Present at Cowen 40 th Annual Healthcare Conference SAN DIEGO--( BUSINESS WIRE )-- DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on the company at the following upcoming investor conference: Steven Pacelli, Executive Vice President, Strategy and Corporate Development, will present an update on the company at the Cowen 40 th Annual Healthcare Conference in Boston, MA, on Monday, March 2, 2020, at 3:30 PM

Feb. 24, 2020 21:03 UTC Fourth Quarter Highlights Net sales of $121.5 million, an increase of 0.3% compared to prior year period and 0.9% on a constant currency basis Kevin Kenny, an experienced spine executive, joins as Global Spine President FDA approval of next generation Bone Growth Therapy patient monitoring app STIM onTrack 2.1 Fiscal Year 2019 Highlights Net sales of $460.0 million, an increase of 1.5% compared to prior year and 2.6% o